Inventor · disambiguated record
Daniel Batlle
Also filed as: BATLLE DANIEL
4 granted patents·5 pending applications·16 citations·filing 2006–2024
71Inventor score
Top patents by PatentIndex Score
9 records- 0189US11078471B2Active low molecular weight variants of angiotensin converting enzyme 2 (ACE2)UNIV NORTHWESTERN·Filed 2019·Granted Aug 3, 2021·5 cites·5 claims
- 0288US10443049B2Active low molecular weight variants of angiotensin converting enzyme 2 (ACE2)UNIV NORTHWESTERN·Filed 2018·Granted Oct 15, 2019·10 cites·18 claims
- 0382US12123036B2Soluble ACE2 variants and uses thereforUNIV NORTHWESTERN·Filed 2021·Granted Oct 22, 2024·1 cites·30 claims
- 0479US2024392274A1Active low molecular weight variants of angiotensin converting enzyme 2 (ace2)UNIV NORTHWESTERN·Filed 2024·Application pending·0 cites
- 0572US11891638B2Active low molecular weight variants of angiotensin converting enzyme 2 (ACE2)UNIV NORTHWESTERN·Filed 2021·Granted Feb 6, 2024·0 cites·13 claims
- 0656US2007105925A1Methods for achieving a protective ACE2 expression level to treat kidney disease and hypertensionBATLLE DANIEL·Filed 2006·Application pending·0 cites
- 0750US2023399360A1Terlipressin-octadecanedioic acid conjugate for vasoconstrictive therapyUNIV NORTHWESTERN·Filed 2020·Application pending·0 cites
- 0849US2021386837A1Active low molecular weight variants of angiotensin converting enzyme 2 (ace2) for the treatment of diseases and conditions of the eyeUNIV NORTHWESTERN·Filed 2021·Application pending·0 cites
- 0948US2011183366A1Methods for achieving a protective ACE2 expression level to treat kidney disease and hypertensionBATLLE DANIEL·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniel Batlle files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →